Menu
You have to log in or sign up before you can proceed.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€208.25
27.12.21
€215.00
27.12.22
23.82%
28.12.22

Could be worthwhile Investment >10% per year
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€208.25
27.12.21
€215.00
27.12.22
23.82%
28.12.22

Could be worthwhile Investment >10% per year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€37.99
27.12.21
€42.00
27.12.22
-5.05%
28.12.22

Could be worthwhile Investment >10% per year
buy
Pluristem Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.41
27.12.21
€2.50
27.12.22
-31.19%
28.12.22

Could be worthwhile Investment >10% per year
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.97
27.12.21
€6.00
27.12.22
-83.85%
28.12.22

Could be worthwhile Investment >10% per year
Krones AG

Start price
Target price
Perf. (%)
€96.30
27.12.21
-
27.12.22
-19.63%
15.03.22

buy
Münchener Rückversicherungs-Gesellschaft AG

Start price
Target price
Perf. (%)
€257.65
27.12.21
-
27.12.22
18.26%
28.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Rational AG

Start price
Target price
Perf. (%)
€899.00
27.12.21
-
27.12.22
-38.15%
28.12.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
buy
Neonode Inc.

Start price
Target price
Perf. (%)
€8.40
26.12.21
€6.00
-
28.05.23

Could be worthwhile Investment >10% per year
buy
PVA TePla AG

Start price
Target price
Perf. (%)
€41.85
26.12.21
€48.00
26.12.22
-6.93%
08.01.22

EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Normal challenges to pay loans and raise capital
buy
Secunet Security AG

Start price
Target price
Perf. (%)
€409.50
26.12.21
€450.00
26.12.22
-8.79%
08.01.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Valuable balance sheet
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.35
26.12.21
-
26.12.22
-7.81%
09.01.22

Risky Investment
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€224.75
25.12.21
€260.00
25.12.22
-14.41%
06.01.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Recon Technology Ltd.

Start price
Target price
Perf. (%)
€1.32
25.12.21
-
25.12.22
-8.14%
26.12.22

Probably not worthwhile Investment
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€10.64
24.12.21
-
24.12.22
-57.99%
25.12.22

Could be worthwhile Investment >10% per year
buy
Zeal Network SE

Start price
Target price
Perf. (%)
€38.00
23.12.21
-
23.12.22
-14.74%
25.08.22

buy
Zalando SE

Start price
Target price
Perf. (%)
€70.18
23.12.21
-
23.12.22
-64.41%
25.08.22

buy
Stratec SE

Start price
Target price
Perf. (%)
€132.00
23.12.21
-
23.12.22
-32.73%
25.08.22

buy
Schaeffler AG

Start price
Target price
Perf. (%)
€7.22
23.12.21
-
23.12.22
-25.97%
25.08.22

buy
ProSiebenSat.1 Media SE

Start price
Target price
Perf. (%)
€13.99
23.12.21
-
23.12.22
-43.53%
25.08.22

buy
Patrizia Immobilien AG

Start price
Target price
Perf. (%)
€20.90
23.12.21
-
23.12.22
-40.29%
25.08.22

buy
K+S AG

Start price
Target price
Perf. (%)
€15.03
23.12.21
-
23.12.22
46.84%
25.08.22

buy
flatexDEGIRO AG

Start price
Target price
Perf. (%)
€21.18
23.12.21
-
23.12.22
-53.13%
25.08.22

buy
Metro AG ST

Start price
Target price
Perf. (%)
€9.39
23.12.21
-
23.12.22
-11.68%
25.08.22

buy
Nagarro SE

Start price
Target price
Perf. (%)
€192.50
23.12.21
-
23.12.22
-40.57%
25.08.22